Literature DB >> 19555713

Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy.

Samar Ojaimi1, Jim P Buttery, Tony M Korman.   

Abstract

Involutional lipoatrophy, a loss of subcutaneous fat, may be idiopathic, associated with inflammatory skin conditions, or trauma, and has also been reported following injections of medications including insulin, corticosteroids and penicillin. There have also been reports in association with Diptheria Pertussis Tetanus (DPT) vaccine. We report on two cases of lipoatrophy associated with the new Quadrivalent Human Papillomavirus (HPV) recombinant vaccine (Gardasil).

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19555713     DOI： 10.1016/j.vaccine.2009.06.026

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  10 in total

1.  Review of Gardasil.

Authors:  Diane M Harper; Stephen L Vierthaler; Jennifer A Santee
Journal:  J Vaccines Vaccin       Date:  2010-11-23

2.  Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018.

Authors:  G Gross; N Becker; N H Brockmeyer; S Esser; U Freitag; M Gebhardt; L Gissmann; P Hillemanns; H Grundhewer; H Ikenberg; H Jessen; A Kaufmann; S Klug; J P Klußmann; A Nast; D Pathirana; K U Petry; H Pfister; U Röllinghof; P Schneede; A Schneider; E Selka; S Singer; S Smola; B Sporbeck; M von Knebel Doeberitz; P Wutzler
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-03       Impact factor: 2.915

Review 3.  Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

Authors:  Liisa K Selin; Myriam F Wlodarczyk; Anke R Kraft; Siwei Nie; Laurie L Kenney; Roberto Puzone; Franco Celada
Journal:  Autoimmunity       Date:  2011-01-20       Impact factor: 2.815

Review 4.  Vaccination and heterologous immunity: educating the immune system.

Authors:  Anna Gil; Laurie L Kenney; Rabinarayan Mishra; Levi B Watkin; Nuray Aslan; Liisa K Selin
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

Review 5.  Pityriasis Lichenoides et Varioliformis Acuta Triggered by Human Papillomavirus Vaccine: A Case Report and Literature Review.

Authors:  Beata A Jastrząb; Aleksandra A Stefaniak; Anita Hryncewicz-Gwóźdź; Piotr Nockowski; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2021-09-17       Impact factor: 3.875

Review 6.  Safety of human papillomavirus vaccines: a review.

Authors:  Kristine K Macartney; Clayton Chiu; Melina Georgousakis; Julia M L Brotherton
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

7.  Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.

Authors:  Alex T Chen; Markus Cornberg; Stephanie Gras; Carole Guillonneau; Jamie Rossjohn; Andrew Trees; Sebastien Emonet; Juan C de la Torre; Raymond M Welsh; Liisa K Selin
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

Review 8.  Best vaccination practice and medically attended injection site events following deltoid intramuscular injection.

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccine.

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2022-03-08       Impact factor: 4.526

10.  Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report.

Authors:  Ernst A Chantelau; Ruth Prätor; Jörg Prätor
Journal:  J Med Case Rep       Date:  2014-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.